Flatiron Health
Latest round
- Series C
Last raised
- Jan 2016
Total raised
- $313M
Investors
- 14
About Flatiron Health
Flatiron Health, Inc.Founded in 2012 and headquartered in New York, US, Flatiron Health, Inc. provides technology solutions for oncology practices. The company was co-founded by Hugh Levaux, who has a history of entrepreneurial ventures.9 billion, marking a significant pivot in its corporate structure.Flatiron Health specializes in technology solutions that enhance cancer care through its core products, primarily including Flatiron Clinical Pipe™ and Flatiron Assist™. Flatiron Clinical Pipe™ integrates electronic health records (EHR) with electronic data capture (EDC) systems, facilitating the seamless transfer of clinical trial data across 85 sites to enhance trial efficiency. Flatiron Assist™ is a clinical decision support tool designed to optimize treatment regimens by aligning with National Comprehensive Cancer Network (NCCN) guidelines, resulting in a significant reduction of 44% in the variety of treatment regimens ordered across participating cancer centers. These solutions are utilized by clinicians, researchers, and healthcare organizations across the United States, with a focus on improving patient experiences and operational efficiencies in oncology.Flatiron Health's revenue model is primarily based on subscription services, partnerships, and direct sales to healthcare providers and institutions. The company engages in B2B transactions, providing its flagship products, such as Flatiron Clinical Pipe™ and Flatiron Assist™, to cancer treatment centers and research institutions. Revenue is generated through contractual agreements that may include ongoing support and updates for its software solutions, as well as tailored services that facilitate clinical research and improve patient care. Specific pricing structures for these services are determined based on the unique needs of each client, often reflecting the level of integration and support required. The company is focused on developing new products that improve cancer care and patient outcomes, although specific details on release dates have not been disclosed. Additionally, Flatiron is considering expanding its market reach into international territories to leverage its expertise in oncology data solutions. The acquisition in February 2018, which is expected to be completed in the first half of that year, will provide substantial resources to support these growth initiatives.
Who invested in Flatiron Health
14 investors across 3 rounds
See all investors in Flatiron Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Flatiron Health
Who invested in Flatiron Health?
Flatiron Health has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Flatiron Health raised?
Flatiron Health has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Flatiron Health last raise money?
Flatiron Health's most recent round on record is a Series C, in Jan 2016.
What does Flatiron Health do?
Flatiron Health is a healthcare it company.
Where is Flatiron Health headquartered?
Flatiron Health is headquartered in New York, US.
Which VCs invest in companies like Flatiron Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Flatiron Health's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series C
Raising like Flatiron Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.